Skip to main content

MBX Biosciences

Carmel, United States

MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.

$63.5M raised
Aug 2024
Series C

Top Investors

Norwest Venture PartnersNew Enterprise AssociatesWellington ManagementOrbiMedRA Capital Management

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about MBX Biosciences

How much funding has MBX Biosciences raised?
MBX Biosciences has raised $63.5M in total funding. The most recent round was Series C. The last funding was announced in August 2024.
Who are MBX Biosciences's investors?
MBX Biosciences's investors include Norwest Venture Partners, New Enterprise Associates, Wellington Management, OrbiMed, RA Capital Management.
Where is MBX Biosciences headquartered?
MBX Biosciences is headquartered in Carmel, United States.
What does MBX Biosciences do?
MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.
What stage is MBX Biosciences at?
MBX Biosciences is at the Series C stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"MBX Biosciences — Funding & Investors." VCBacked, August 5, 2024, https://www.vcbacked.co/company/mbx-biosciences. Accessed June 3, 2026.
APA
VCBacked. (2024). MBX Biosciences — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/mbx-biosciences
Wikipedia (cite web)
{{cite web |title=MBX Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/mbx-biosciences |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .